Copeptin and Mid-Regional Proadrenomedullin Are Not Useful Biomarkers of Cardiometabolic Disease in Patients with Acromegaly—A Preliminary Study

Copeptin and Mid-Regional Proadrenomedullin Are Not Useful Biomarkers of Cardiometabolic Disease in Patients with Acromegaly—A Preliminary Study

<b>Background/Objectives:</b> Cardiovascular complications are a leading cause of premature mortality in patients with acromegaly. Copeptin (CPP) correlates strongly with plasma osmolality and is regulated by non-osmotic stimuli involved in the pathophysiology of cardiovascular disease....

Full description

Saved in:
Bibliographic Details
Main Authors: Martyna Strzelec, Eliza Kubicka, Justyna Kuliczkowska-Płaksej, Katarzyna Kolačkov, Łucja Janek, Marek Bolanowski, Aleksandra Jawiarczyk-Przybyłowska
Format: Article
Language:English
Published: MDPI AG 2025-03-01
Series:Biomedicines
Subjects:
acromegaly
cardiovascular diseases
copeptin
mid-regional proadrenomedullin
Online Access:https://www.mdpi.com/2227-9059/13/3/666
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items